https://www.selleckchem.com/pr....oducts/Temsirolimus.
RESULTS CCS uptake remained relatively stable over time, with a mean coverage of 70.9% in Belgium and 73.1% in Switzerland. Educational and income gradients were found in both countries. Concerning CCS overuse, women above screening-eligible age showed consistently high screening rates, but screening within the past year declined significantly in both countries, matching the temporal implementation of the reimbursement initiatives. CONCLUSIONS Although no increase in CCS coverage could be established, CCS has become more efficient
Like
Comment
Share